Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05794022

Cohort of STEMI Patients 2

CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort). The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.

Conditions

Interventions

TypeNameDescription
OTHERMRI1 MRI at 1 month with gadolinium injection
BIOLOGICALBiocollectionBiocollection from blood (H0, H4, H24, H48, 1 month, 1 year), urine (H48) and faecal (initial hospitalisation) samples.
BEHAVIORALQuality of life questionariesEQ-5D-5L and HAD questionaries at 1 month and 1 year.

Timeline

Start date
2023-05-03
Primary completion
2031-06-03
Completion
2031-06-03
First posted
2023-03-31
Last updated
2026-01-30

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05794022. Inclusion in this directory is not an endorsement.